Osteoprotegerin and Mortality in Type 2 Diabetic Patients

OBJECTIVE: Plasma osteoprotegerin (OPG) is an emerging strong and independent predictor of cardiovascular disease (CVD) in high-risk populations. OPG is a bone-related glycopeptide produced by vascular smooth muscle cells, and increased plasma OPG levels may reflect arterial vascular damage. We aime...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Reinhard, Henrik, Lajer, Maria, Gall, Mari-Anne, Tarnow, Lise, Parving, Hans-Henrik, Rasmussen, Lars M., Rossing, Peter
Formato: Artigo
Idioma:Inglês
Publicado: American Diabetes Association 2010
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2992191/
https://ncbi.nlm.nih.gov/pubmed/20929997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc10-0858
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares